Related references
Note: Only part of the references are listed.The Effect of Metal Imbalances on Scrapie Neurodegeneration
P. Hortells et al.
ZOONOSES AND PUBLIC HEALTH (2010)
Role of copper and manganese in prion disease progression
Gerda Mitteregger et al.
BRAIN RESEARCH (2009)
Therapeutic interventions ameliorating prion disease
Marcus W. Brazier et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2009)
The effects of prion protein expression on metal metabolism
Silvia Kralovicova et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2009)
Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial (vol 7, pg 779, 2008)
L. Lannfelt et al.
LANCET NEUROLOGY (2009)
Manganese Enhances Prion Protein Survival in Model Soils and Increases Prion Infectivity to Cells
Paul Davies et al.
PLOS ONE (2009)
Metal-dependent generation of reactive oxygen species from amyloid proteins implicated in neurodegenerative disease
David Allsop et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2008)
Manganese binding to the prion protein
Marcus W. Brazier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Resistance of cell lines to prion toxicity aided by phospho-ERK expression
Kay M. Uppington et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Effective Gene Therapy in a Mouse Model of Prion Diseases
Karine Toupet et al.
PLOS ONE (2008)
Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease:: a phase IIa, double-blind, randomised, placebo-controlled trial
Lars Lannfelt et al.
LANCET NEUROLOGY (2008)
Formation of native prions from minimal components in vitro
Nathan R. Deleault et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Simvastatin prolongs survival times in prion infections of the central nervous system
Simon Wing Fai Mok et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Delineating common molecular mechanisms in Alzheimer's and prion diseases
Kevin J. Barnham et al.
TRENDS IN BIOCHEMICAL SCIENCES (2006)
Effect of copper and manganese on the de novo generation of protease-resistant prion protein in yeast cells
Carina Treiber et al.
BIOCHEMISTRY (2006)
Potent antiscrapie activities of degenerate phosphorothioate oligonucleotides
DA Kocisko et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Correlative studies support lipid peroxidation is linked to PrPres propagation as art early primary pathogenic event in prion disease
MW Brazier et al.
BRAIN RESEARCH BULLETIN (2006)
The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy
A Gaeta et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
High affinity binding between copper and full-length prion protein identified by two different techniques
AR Thompsett et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Extended period of asymptomatic prion disease after low dose inoculation: Assessment of detection methods and implications for infection control
SJ Collins et al.
NEUROBIOLOGY OF DISEASE (2005)
The most infectious prion protein particles
JR Silveira et al.
NATURE (2005)
Single particle analysis of manganese-induce prion protein aggregates
J Levin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Interaction of the human prion PrP(106-126) sequence with copper(II), manganese(II), and zinc(11): NMR and EPR studies
E Gaggelli et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Treatment of transmissible spongiform encephalopathy by intraventricular drug infusion in animal models
K Doh-Ura et al.
JOURNAL OF VIROLOGY (2004)
Effect of metal ions on de novo aggregation of full-length prion protein
A Giese et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Prion protein fate governed by metal binding
RN Tsenkova et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Copper binding to PrPC may inhibit prion disease propagation
N Hijazi et al.
BRAIN RESEARCH (2003)
Copper chelation delays the onset of prion disease
EM Sigurdsson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
RNA molecules stimulate prion protein conversion
NR Deleault et al.
NATURE (2003)
Copper coordination in the full-length, recombinant prion protein
CS Burns et al.
BIOCHEMISTRY (2003)
Monoclonal antibodies inhibit prion replication and delay the development of prion disease
AR White et al.
NATURE (2003)
Detection of bovine spongiform encephalopathy, ovine scrapie prion-related protein (PrPSc) and normal PrPc by monoclonal antibodies raised to copper-refolded prion protein
AM Thackray et al.
BIOCHEMICAL JOURNAL (2003)
Quinacrine does not prolong survival in a murine Creutzfeldt-Jakob disease model
SJ Collins et al.
ANNALS OF NEUROLOGY (2002)
Postexposure prophylaxis against prion disease with a stimulator of innate immunity
S Sethi et al.
LANCET (2002)
Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo
DM Walsh et al.
NATURE (2002)
Metal imbalance and compromised antioxidant function are early changes in prion disease
AM Thackray et al.
BIOCHEMICAL JOURNAL (2002)
Aberrant metal binding by prion protein in human prion disease
BS Wong et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Location and properties of metal-binding sites on the human prion protein
GS Jackson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Copper and zinc binding modulates the aggregation and neurotoxic properties of the prion peptide PrP106-126
MF Jobling et al.
BIOCHEMISTRY (2001)
Treatment with a copper-zinc chelator markedly and rapidly inhibits β-amyloid accumulation in Alzheimer's disease transgenic mice
RA Cherny et al.
NEURON (2001)
Consequences of manganese replacement of copper for prion protein function and proteinase resistance
DR Brown et al.
EMBO JOURNAL (2000)
Porphyrin and phthalocyanine antiscrapie compounds
SA Priola et al.
SCIENCE (2000)
Share Paper
